Background and objectives The risk assessment for developing ESRD remains limited in patients with IgA nephropathy (IgAN). 1.10 to 3.11), segmental sclerosis (HR, 3.21; 95% CI, 1.37 to 7.51), and interstitial fibrosis/tubular atrophy (T1: HR, 5.30; 95% CI, 2.63 to 10.7; T2: HR, 20.5; LY315920 95% CI, 9.05 to 46.5) as indie risk factors for… Continue reading Background and objectives The risk assessment for developing ESRD remains limited